Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-207,120
Closed -$10.7M 890
2025
Q4
$10.7M Buy
207,120
+14,730
+8% +$900K 0.02% 538
2025
Q3
$14.3M Buy
192,390
+12,578
+7% +$923K 0.03% 454
2025
Q2
$13.7M Buy
179,812
+10,583
+6% +$762K 0.03% 450
2025
Q1
$11.8M Buy
169,229
+26,908
+19% +$1.86M 0.03% 426
2024
Q4
$8.71M Buy
+142,321
New +$9.3M 0.02% 466

Other funds holding NTNX

Aviva's NTNX Position: Q1 2026 in Review

Aviva sold out of Nutanix (NTNX) in Q1 2026, closing a stake of 207,120 shares — an estimated $10.7M sold.

Aviva first reported a position in NTNX in Q4 2024 and held it in 5 quarters. The position peaked at $14.3M in Q3 2025. 538 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • Aviva reported no remaining Nutanix position as of Q1 2026 after selling out during the quarter.
  • Aviva sold 207,120 Nutanix shares in Q1 2026, an estimated $10.7M.
  • Aviva first reported a position in Nutanix in Q4 2024 and held it in 5 quarters.
  • Aviva's Nutanix position peaked at $14.3M in Q3 2025.
  • 538 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.